Stock Earnings

Question 1

Fulcrum Therapeutics Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Fulcrum Therapeutics Inc 的总资产为 $260，净loss为 $-9

Question 2

FULC 的关键财务比率是什么？

Accepted Answer

Fulcrum Therapeutics Inc 的流动比率是 15.29，净利 margin 为 -11.25，每股销售为 $1.29。

Question 3

Fulcrum Therapeutics Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Fulcrum Therapeutics Inc largest revenue segment is Biopharmaceutical, at a revenue of 80,000,000 in the most earnings release.For geography, United States is the primary market for Fulcrum Therapeutics Inc, at a revenue of 80,000,000.

Question 4

Fulcrum Therapeutics Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Fulcrum Therapeutics Inc 的净loss为 $-9

Question 5

Fulcrum Therapeutics Inc 有负债吗？

Accepted Answer

yes，Fulcrum Therapeutics Inc 的负债为 17

Question 6

Fulcrum Therapeutics Inc 的流通股有多少？

Accepted Answer

Fulcrum Therapeutics Inc 的总流通股为 53.96

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	80	2	6	19	8
Revenue Growth (YoY)	-100%	3,900%	-67%	-68%	138%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	22	36	41	41	30	21
Research & Development	38	63	71	76	69	59
Operating Expenses	61	99	113	118	100	80
Other Non Operating Income (Expenses)	7	12	13	2	0	0
Pretax Income	-53	-9	-97	-109	-80	-70
Income Tax Expense	--	--	--	--	--	--
Net Income	-53	-9	-97	-109	-80	-70
Net Income Growth	212%	-91%	-11%	36%	14%	-21%
Shares Outstanding (Diluted)	62.59	61.98	61.31	44.99	35.36	25.35
Shares Change (YoY)	0%	1%	36%	27%	39%	12%
EPS (Diluted)	-0.85	-0.15	-1.58	-2.44	-2.29	-2.79
EPS Growth	206.99%	-90%	-35%	7%	-18%	-30%
Free Cash Flow	-60	-2	-91	-99	-80	-55
Free Cash Flow Per Share	-0.95	-0.03	-1.48	-2.2	-2.26	-2.16
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-23.75%	-5,500%	-1,866.66%	-426.31%	-887.5%
Profit Margin	0%	-11.25%	-4,850%	-1,816.66%	-421.05%	-875%
Free Cash Flow Margin	0%	-2.5%	-4,550%	-1,650%	-421.05%	-687.5%
EBITDA	-60	-18	-108	-110	-79	-69
EBITDA Margin	0%	-22.5%	-5,400%	-1,833.33%	-415.78%	-862.5%
D&A For EBITDA	1	1	2	2	2	2
EBIT	-61	-19	-110	-112	-81	-71
EBIT Margin	0%	-23.75%	-5,500%	-1,866.66%	-426.31%	-887.5%
Effective Tax Rate	--	--	--	--	--	--

Fulcrum Therapeutics Inc (FULC) Price

FULC Stock Price Chart

FULC Income

Follow-Up Questions